EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Open Access

A Phase II Clinical Trial of Chemotherapy Rechallenge with or without Targeted Therapy in Refractory Metastatic Colorectal Cancer

Chenchen Wang, Mingzhu Huang, Wenhua Li, Xuedan Sheng, Xiaoying Zhao, Xiaodong Zhu, Zhiyu Chen, Zhe Zhang, Haiming Li, Weijian Guo

Oncology Research · 2026 · 1-10

DOI: 10.32604/or.2026.084378 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift Oncology Research, 2026. Verfasst von Chenchen Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Colorectal Neoplasms. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic Combined Chemotherapy ProtocolsColorectal NeoplasmsAdultAgedFemaleHumansMaleMiddle AgedBevacizumabCetuximabDrug Resistance, NeoplasmIrinotecanMolecular Targeted TherapyNeoplasm MetastasisOxaliplatinQuinazolinesTreatment OutcomeThiophenes

Stichwörter der Autor:innen

Colorectal cancerclinical trialrechallenge therapyrefractory disease

Substanzen

BevacizumabCetuximabIrinotecanOxaliplatinQuinazolinesraltitrexedThiophenes

Autor:innen und Institutionen

  • Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, China.

Zitieren

APA

Wang, C., Huang, M., Li, W., Sheng, X., Zhao, X., Zhu, X., Chen, Z., Zhang, Z., Li, H., & Guo, W. (2026). A Phase II Clinical Trial of Chemotherapy Rechallenge with or without Targeted Therapy in Refractory Metastatic Colorectal Cancer. Oncology Research, 0(0), 1-10. https://doi.org/10.32604/or.2026.084378

Vancouver

Wang C, Huang M, Li W, Sheng X, Zhao X, Zhu X, et al. A Phase II Clinical Trial of Chemotherapy Rechallenge with or without Targeted Therapy in Refractory Metastatic Colorectal Cancer. Oncology Research. 2026;0(0):1-10. doi:10.32604/or.2026.084378

BibTeX
@article{Wang2026,
  author = {Wang, Chenchen and Huang, Mingzhu and Li, Wenhua and Sheng, Xuedan and Zhao, Xiaoying and Zhu, Xiaodong and Chen, Zhiyu and Zhang, Zhe and Li, Haiming and Guo, Weijian},
  title = {A Phase II Clinical Trial of Chemotherapy Rechallenge with or without Targeted Therapy in Refractory Metastatic Colorectal Cancer},
  journal = {Oncology Research},
  year = {2026},
  volume = {0},
  number = {0},
  pages = {1--10},
  doi = {10.32604/or.2026.084378}
}
Kostenlos starten →